Hugh is the co-inventor of the founding technology for Respira and thought leader in pulmonary drug delivery science. He is currently the Bergen-Brunswig Fellow and Associate Professor of Pharmaceutics at the University of Texas at Austin, College of Pharmacy and also is an Adjunct Associate Scientist at Lovelace Respiratory Research Institute in Albuquerque, New Mexico. He received his Ph.D. in Drug Delivery from the University of Otago in New Zealand, in collaboration with GlaxoWelcome, USA. Following a post doc and two years as a Research Assistant Professor at University of North Carolina, he took a faculty position at the University of New Mexico (2005) and moved to Texas in 2009. Hugh is the Editor in Chief of the journal Drug Development and Industrial Pharmacy. He has published over 55 scientific peer-reviewed manuscripts, has 18 patent applications pending, and is editor of three books and author of numerous book chapters. In 2007, Hugh was awarded the 2007 AAPS New Investigator Award in Pharmaceutics and Pharmaceutical Technologies, and also the 2007 Pharmaceutical Research and Manufacturers Association New Investigator Award.

Pulmonary Medicine